First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research Fremont, California. Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the expansion of its NULISAseq™ CNS Disease Panel 120 to include novel assays for brain-derived phosphorylated tau (pTau) proteins. The enhanced panel now […]
N of 1 therapy uniquely developed, on demand, for infant with life-threatening rare metabolic disorder in six months Results published in The New England Journal of Medicine and showcased at American Society of Gene & Cell Therapy Annual Meeting Fargo, ND and Coralville, IA — Aldevron, a global leader in the production of DNA, RNA […]
SAN DIEGO – Element Biosciences, Inc., a company democratizing access to advanced life science solutions, today announced that Madhuri Hegde, Ph.D., has joined its board of directors. Dr. Hegde currently serves as senior vice president and Chief Scientific Officer at Revvity, Inc., where she leads the strategic scientific direction of the company. A board-certified diplomate in clinical molecular […]
SAN DIEGO — Today, TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, and the International Vaccine Institute (IVI), a non-profit international organization devoted to and the discovery, development and delivery of vaccines for global health signed a Memorandum of Understanding to collaborate to advance the research and […]
Empowering Japanese Researchers with End to End Genomic Solutions Partnering with Basepair allows us to deliver a solution that meets modern R&D needs without increasing infrastructure burden.” — Yoshiko Iwai, President & CEO of Iwai Chemicals NEW YORK, NY, UNITED STATES — Basepair Inc. and IWAI Chemicals Co., Ltd. today announced a strategic partnership to bring […]
PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that it has reached a settlement agreement with Bruker Corporation, successfully resolving all outstanding worldwide patent litigation and disputes between the two companies. As part of the settlement, 10x expects that Bruker will pay $68 million in equal quarterly installments between […]
PALO ALTO, Calif. — Countable Labs (formerly Enumerix) entered the genomics market with the launch of Countable PCR, redefining what’s possible with PCR for rare event detection. By delivering 10 times more sensitivity and 10 times lower CVs than digital PCR, Countable PCR gives scientists the confidence they’ve been looking for when quantifying rare events, […]
ST. PAUL, Minn. — ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady announced today three G-Rex Grants that have been awarded to faculty members at the University of Southern California (USC) and the Children’s Hospital of Los Angeles (CHLA). The funding totaling $1,025,000 will support the translation of various cell and […]
BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) today announced that Bruker and 10x Genomics have reached a final settlement to resolve their patent disputes and dismiss multiple litigations, with global patent cross license agreements between the two companies. In connection with the settlement, all ongoing lawsuits and administrative proceedings filed by both companies in several countries, including […]
ALAMEDA, Calif. and PRINCETON, N.J. — CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic collaboration to generate pilot data on the CellFE High Volume Cyva™ System. This partnership will validate the clinical-scale performance of CellFE’s innovative, non-viral gene editing microfluidics technology for both activated […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
